HOYA (HOCPY) AI Stock Analysis

37 Followers

HOYA

(Other OTC:HOCPY)

Select Model

Rating:77Outperform

Price Target:$169.00▲(13.22% Upside)

Action:reiterated

Date:11/01/26

The score is driven primarily by high-quality financials—exceptional margins, strong ROE, conservative leverage, and solid cash conversion—partly offset by slowing revenue growth. Technicals are constructive with positive trend and momentum, though short-term indicators suggest the move may be extended. Valuation is the main constraint, as the premium P/E and modest dividend yield reduce upside cushion.

Positive Factors

High ProfitabilityHOYA’s exceptionally strong gross, operating, and net margins indicate substantial earnings power across its businesses. Such profitability provides resilience against moderate demand changes and supports continued investment, product development, and shareholder returns without requiring aggressive financial leverage.

Negative Factors

Slowing Revenue GrowthDecelerating top-line growth could limit future earnings expansion if HOYA cannot offset slower demand with new products, higher volumes, or further mix improvement. A slower revenue base also makes continued profit growth more dependent on maintaining already elevated margins.

HOYA (HOCPY) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $50.12B
Dividend Yield: 1.36%
Average Volume (3M): 33.12K
Price to Earnings (P/E): 28.9
Beta (1Y): 0.85
Revenue Growth: 7.04%
EPS Growth: 31.05%
Country: US
Employees: 37,752
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

HOYA Business Overview & Revenue Model

Company Description

Established in Tokyo, Japan, in 1941, HOYA Corporation operates as a global med-tech enterprise and a leading provider of advanced technological and medical solutions. Its extensive "life care" division offers a diverse portfolio, ranging from ophtha...

How the Company Makes Money

HOYA makes money primarily by selling products and solutions across its major business lines, with revenue generally generated through a mix of high-volume consumables and higher-value equipment. 1) Vision Care (eyeglass lenses): HOYA generates reven...

HOYA Financial Statement Overview

Summary

Strong profitability (TTM gross margin ~78.5%, net margin ~28.0%, EBIT margin ~35.3%) and high returns (ROE ~27.7%) supported by very low leverage (debt-to-equity ~0.04). Cash generation is solid with operating cash flow ~1.48x net income and free cash flow ~81% of net income. Main risk noted is moderating revenue growth (TTM ~2.1%), which could limit future earnings expansion if margins normalize.

Income Statement

86Very Positive

Balance Sheet

92Very Positive

Cash Flow

84Very Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Income Statement
Total Revenue	927.15B	885.82B	1.00T	762.61B	734.10B	670.33B
Gross Profit	765.40B	766.25B	793.79B	421.69B	631.86B	567.28B
EBITDA	451.54B	310.00B	359.07B	285.70B	259.78B	243.96B
Net Income	253.01B	202.10B	268.35B	181.38B	168.64B	164.51B
Balance Sheet
Total Assets	1.31T	1.23T	1.31T	1.20T	1.03T	992.84B
Cash, Cash Equivalents and Short-Term Investments	580.98B	538.53B	576.58B	525.16B	426.27B	426.63B
Total Debt	41.46B	37.28B	42.42B	29.24B	24.58B	21.60B
Total Liabilities	264.40B	262.65B	267.05B	241.36B	213.72B	203.78B
Stockholders Equity	1.03T	974.02B	1.02T	967.76B	818.32B	803.85B
Cash Flow
Free Cash Flow	153.05B	187.19B	235.25B	181.73B	168.36B	161.18B
Operating Cash Flow	194.99B	235.11B	295.24B	222.80B	201.83B	190.06B
Investing Cash Flow	8.07B	-33.19B	-8.04B	-35.81B	-47.50B	-29.30B
Financing Cash Flow	-214.81B	-190.35B	-277.01B	-110.89B	-194.59B	-106.72B

HOYA Technical Analysis

Technical Analysis SentimentNegative

Last Price149.27

Price Trends

50DMA154.49Negative

100DMA156.04Negative

200DMA165.45Negative

Market Momentum

MACD-2.50Positive

RSI39.66Neutral

STOCH25.87Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HOCPY, the sentiment is Negative. The current price of 149.27 is below the 20-day moving average (MA) of 159.33, below the 50-day MA of 154.49, and below the 200-day MA of 165.45, indicating a bearish trend. The MACD of -2.50 indicates Positive momentum. The RSI at 39.66 is Neutral, neither overbought nor oversold. The STOCH value of 25.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HOCPY.

HOYA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

HOCPY against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ISRG	84Outperform	$156.00B	53.71	17.03%	―	20.45%	8.75%
HOCPY	77Outperform	$49.17B	28.87	27.70%	1.36%	7.04%	31.05%
BLCO	65Neutral	$7.64B	-68.84	-1.73%	―	8.88%	63.73%
BDX	63Neutral	$57.91B	51.69	3.67%	1.85%	-7.40%	-28.89%
STAA	59Neutral	$1.20B	2669.00	0.15%	―	42.36%	―
COO	58Neutral	$12.09B	21.48	6.88%	―	4.73%	43.89%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

HOCPY and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HOCPY	Hoya Corp	149.27	-8.50	-5.39%
BDX	Becton, Dickinson and Co	214.52	66.52	44.95%
COO	Cooper Companies	62.93	-8.82	-12.29%
ISRG	Intuitive Surgical	449.53	-115.98	-20.51%
STAA	Staar Surgical Company	26.69	0.66	2.54%
BLCO	Bausch + Lomb Corporation	21.32	5.63	35.88%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 01, 2026

HOYA AI Stock Analysis